Development and validation of disulfidptosis-related genes signature for patients with glioma
The disulfidptosis-related gene-based risk score model effectively predicted glioma outcomes and highlighted the role of disulfidptosis-related genes in tumor immunity. This study offers potential new avenues for glioma treatment by targeting disulfidptosis.
Authors
- Sha Yang
- Peng Chen (ORCID: https://orcid.org/0000-0001-6028-383X)
- Ying Ching Tan (ORCID: https://orcid.org/0000-0003-2957-0165)
- Yongbing Deng (ORCID: https://orcid.org/0000-0002-8581-5748)
- Jia Wang (ORCID: https://orcid.org/0000-0002-4746-035X)
- Juhua Luo (ORCID: https://orcid.org/0000-0002-4615-6006)
- Yang Liu (ORCID: https://orcid.org/0000-0001-5586-623X)
Institutions
- Chongqing University (CN)
- Guizhou University (CN)
- Zunyi Medical University (CN)
- Chongqing Emergency Medical Center (CN)
- Guizhou Provincial People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1007/s12672-024-01664-z
- Citations
- 1
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- National Science Foundation
- National Natural Science Foundation of China